GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production ...Middle East

Sterling to Manufacture GNX102-ADC for Planned Phase 1 Clinical Program NEW TAIPEI CITY, Taiwan, Nov. 12, 2024 /PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer...

Read More Details
Finally We wish PressBee provided you with enough information of ( GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production )

Also on site :

• Harris Dickinson On The Inspiration For Cannes Directing Debut ‘Urchin’ And Why Upcoming John Lennon Role Is His “Every Day Right Now”
• Pursuit of stolen car ends with suspect crashing in North Highlands
• May 17, 2025